PsiThera

Private

Watertown, MassachusettsHealthcare & Life Scienceshttps://psithera.com/

Last Round

Series A

Dec 10, 2025

Total Funding Raised

$95M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PsiThera is a biotechnology company that develops oral small-molecule medicines for immunology and inflammatory diseases using its proprietary QUAISAR computational intelligence platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Infrastructure

Keywords

drug discoverycomputational drug discoverysmall-molecule therapeuticsAI drug discoveryin silico drug designprotein motion modelingquantum chemistrymolecular dynamicsbiotechnologyhigh-performance computingHPCpreclinical pipelineTNF superfamilydrug discovery platformbiotech platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PsiThera Comps

Public and private peers based on sector, stage, and business model.

PsiThera comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PsiThera Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Dec 10, 2025
Series A	Dec 10, 2025

View all Funding Rounds

PsiThera Investors

Notable investors and investment history

PsiThera investors
Investor	Rounds
Lightstone Ventures	Series A
Eurofarma Ventures	Series A
Samsara BioCapital	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 17, 2025
Eric Shaff, formerly of Seres Therapeutics, named new CEO.
Dec 10, 2025
$48M round completed.

View all signals

PsiThera Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

PsiThera Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PsiThera's valuation, stock price, and market status.

Firmographic Details

HeadquartersWatertown, Massachusetts

Year Founded2022

Last FundingDec 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.